These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26038527)

  • 21. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
    Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
    Larsen CP; Beggs ML; Saeed M; Walker PD
    J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity unmasks APOL1 in collapsing glomerulopathy.
    McNicholas BA; Nelson PJ
    Kidney Int; 2015 Feb; 87(2):270-2. PubMed ID: 25635718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?
    Olabisi O; Al-Romaih K; Henderson J; Tomar R; Drummond I; MacRae C; Pollak M
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):114-118. PubMed ID: 27509583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
    Sampson MG; Robertson CC; Martini S; Mariani LH; Lemley KV; Gillies CE; Otto EA; Kopp JB; Randolph A; Vega-Warner V; Eichinger F; Nair V; Gipson DS; Cattran DC; Johnstone DB; O'Toole JF; Bagnasco SM; Song PX; Barisoni L; Troost JP; Kretzler M; Sedor JR;
    J Am Soc Nephrol; 2016 Mar; 27(3):814-23. PubMed ID: 26150607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.
    Nichols B; Jog P; Lee JH; Blackler D; Wilmot M; D'Agati V; Markowitz G; Kopp JB; Alper SL; Pollak MR; Friedman DJ
    Kidney Int; 2015 Feb; 87(2):332-42. PubMed ID: 25100047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 28. Glomerular disease: innate immunity-APOL1 interaction.
    Sidaway P
    Nat Rev Nephrol; 2014 Oct; 10(10):543. PubMed ID: 25157835
    [No Abstract]   [Full Text] [Related]  

  • 29. APOL1 genotyping of African American deceased organ donors: not just yet.
    Ojo A; Knoll GA
    Am J Transplant; 2015 Jun; 15(6):1457-8. PubMed ID: 25809950
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetics. Kidney disease is parasite-slaying protein's downside.
    Leslie M
    Science; 2010 Jul; 329(5989):263. PubMed ID: 20647431
    [No Abstract]   [Full Text] [Related]  

  • 31. Collapsing Glomerulopathy.
    Koirala A; Akilesh S; Jefferson JA
    Adv Kidney Dis Health; 2024 Jul; 31(4):290-298. PubMed ID: 39084754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1 Variants: From Parasites to Kidney Function to Cardiovascular Disease.
    Reiner AP; Susztak K
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):219-20. PubMed ID: 26819463
    [No Abstract]   [Full Text] [Related]  

  • 33. Focal segmental glomerulosclerosis: cellular variant and beyond.
    Nair R
    Kidney Int; 2006 Nov; 70(10):1676-8. PubMed ID: 17080157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemostatic Factors, APOL1, and ESRD Risk: Another Piece of the Puzzle?
    Wasser WG; Kruzel-Davila E
    Clin J Am Soc Nephrol; 2015 May; 10(5):723-5. PubMed ID: 25887068
    [No Abstract]   [Full Text] [Related]  

  • 35. Transplantation: APOL1 gene variants associated with renal allograft failure.
    Kelsey R
    Nat Rev Urol; 2015 May; 12(5):238. PubMed ID: 25868560
    [No Abstract]   [Full Text] [Related]  

  • 36. APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
    Papeta N; Kiryluk K; Patel A; Sterken R; Kacak N; Snyder HJ; Imus PH; Mhatre AN; Lawani AK; Julian BA; Wyatt RJ; Novak J; Wyatt CM; Ross MJ; Winston JA; Klotman ME; Cohen DJ; Appel GB; D'Agati VD; Klotman PE; Gharavi AG
    J Am Soc Nephrol; 2011 Nov; 22(11):1991-6. PubMed ID: 21997397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond APOL1: Genetic Inroads into Understanding Population Disparities in Diabetic Kidney Disease.
    Skorecki K; Wasser WG
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):928-931. PubMed ID: 27197913
    [No Abstract]   [Full Text] [Related]  

  • 38. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
    Ma L; Shelness GS; Snipes JA; Murea M; Antinozzi PA; Cheng D; Saleem MA; Satchell SC; Banas B; Mathieson PW; Kretzler M; Hemal AK; Rudel LL; Petrovic S; Weckerle A; Pollak MR; Ross MD; Parks JS; Freedman BI
    J Am Soc Nephrol; 2015 Feb; 26(2):339-48. PubMed ID: 25012173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
    Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
    J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.